ValiRx appoints Seppo Mäkinen as Non-Executive Director and Oliver de Giorgio-Miller as Non-Executive Chairman

– UK, London – ValiRx Plc (AIM: VAL), a life science company with a focus on cancer diagnostics and personalised therapeutic development announces the following board changes:

  • Appointment of Mr Seppo Olavi Mäkinen as a Non-Executive Director of the Company

Seppo Mäkinen has more than 25 years of senior advisory and executive experience in board level strategic leadership and venture capital management on life science.…